HighMark Wealth Management’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-50
| Closed | -$64 | – | 597 |
|
|
2024
Q4 | $64 | Hold |
50
| – | – | ﹤0.01% | 565 |
|
|
2024
Q3 | $104 | Hold |
50
| – | – | ﹤0.01% | 580 |
|
|
2024
Q2 | $191 | Hold |
50
| – | – | ﹤0.01% | 564 |
|
|
2024
Q1 | $237 | Hold |
50
| – | – | ﹤0.01% | 550 |
|
|
2023
Q4 | $214 | Hold |
50
| – | – | ﹤0.01% | 555 |
|
|
2023
Q3 | $155 | Hold |
50
| – | – | ﹤0.01% | 549 |
|
|
2023
Q2 | $225 | Hold |
50
| – | – | ﹤0.01% | 539 |
|
|
2023
Q1 | $285 | Hold |
50
| – | – | ﹤0.01% | 575 |
|
|
2022
Q4 | $302 | Hold |
50
| – | – | ﹤0.01% | 510 |
|
|
2022
Q3 | $0 | Hold |
50
| – | – | ﹤0.01% | 551 |
|
|
2022
Q2 | $0 | Hold |
50
| – | – | ﹤0.01% | 534 |
|
|
2022
Q1 | $0 | Hold |
50
| – | – | ﹤0.01% | 531 |
|
|
2021
Q4 | $1K | Buy |
+50
| New | +$1K | ﹤0.01% | 478 |
|